No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Brentuximab vedotin with nivolumab was well-tolerated and showed durable remissions as initial salvage therapy in relapsed/refractory classic Hodgkin’s Lymphoma

byKathleen Lau

August 20, 2021

in StudyGraphics

Altering electronic medical records may increase naloxone prescriptions

RelatedReports

Patients with advanced adenomas are at increased risk of developing colorectal cancer

AI Roundup

AstraZeneca moves to own multimodal oncology AI with Modella

January 21, 2026

AI Roundup

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

January 19, 2026

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Weekly Rewinds

2 Minute Medicine Rewind

January 13, 2026

Testosterone replacement in male cancer survivors helps improve body composition

Oncology

New model enhances prediction of prostate cancer-specific mortality

January 12, 2026

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

2 Minute Medicine Rewind August 23, 2021

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Low-intensity pulsed ultrasound decreases major amputation in patients with critical limb ischemia

CT texture analysis may predict liver insufficiency after hepatectomy

Combination of buprenorphine and naloxone may be safe for those hospitalized with acute hepatitis A

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports